Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2004

View Archived Issues

beta-Amyloid immunization improves cognition in a mouse model of Alzheimer's disease

Novel antimitotic agent circumvents tumor resistance in vivo

Pulmonary administration of levodopa improves efficacy in rat model of Parkinson's disease

Bryostatin 1 improves pathophysiology and cognitive impairment in mouse model of AD

European approval for MabThera for first-line treatment of indolent NHL

Mobic approved for use in rheumatoid arthritis

New phase I study begins for GT389-255 for obesity

New program evaluates Modrenal in pre- and postmenopausal women

New U.K. phase I study investigates systemic administration of Reolysin

Mpex files IND for phase Ib study of MP-601205 for infections in CF patients

Quadramet to be investigated in a novel trial in high-risk prostate cancer patients

Enrollment to resume in optional retreatment arm of phase I/II Nuvion study

Pfizer decribes new MK-2 inhibitors and their use

Novel PDE4 inhibitors covered by GSK patent

Sankyo researchers present a new peptide-based antifungal agent

Novel anti-HIV agents targeting CCR5 receptors identified at Schering-Plough

Novartis claims new PCaR antagonists for use as PTH secretion promoters

Novel TNF-alpha production inhibitors under evaluation at Abbott

Neurogen scientists prepare new vanilloid VR1 antagonists for pain management

Neuropharma raises funding via private placement

AVI BioPharma signs CRADA with USAMRIID

European orphan drug designation for acetylsalicylic acid in polycythemia vera

Bradley completes acquisition of Bioglan

Treatment commences in U.K. phase II study of clofarabine for adult AML

Lilly to proceed with late-stage development of inhaled insulin

Preliminary immune response analysis completed for phase II StreptAvax study

FDA approves expanded indication for Humira to improve physical function in RA patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...